drugset / Trial / NCT01959685
A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal
NaSingle-groupOpen-labelTreatment
Summary
To determine the tolerability and pharmacokinetics (PK) of a single dose of Androxal in healthy adult male subjects as the dose to be investigated in a thorough QT interval/corrected QT interval (QT/QTc) study.
Timeline
- Start
- 2013-10
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Androxal | Unknown | 125 mg | — |
| Subject | Androxal | Unknown | 250 mg | — |
Indications
No indication recorded.